TradeLink Capital’s Bristol-Myers Squibb BMY Stock Holding History

TradeLink Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-5,280	Closed	-$310K	–	9
2020 Q2	$310K	Buy	+5,280	New	+$316K	1.29%	31
2014 Q4	–	Sell	-100	Closed	-$5K	–	421
2014 Q3	$5K	Buy	+100	New	+$5K	0.01%	223
2013 Q4	–	Sell	-800	Closed	-$37K	–	187
2013 Q3	$37K	Sell	800 -31,800	-98%	-$1.4M	0.09%	203
2013 Q2	$1.46M	Buy	+32,600	New	+$1.42M	0.45%	31

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

TradeLink Capital's BMY Position: Q3 2020 in Review

TradeLink Capital sold out of Bristol-Myers Squibb (BMY) in Q3 2020, closing a stake of 5,280 shares — an estimated $310K sold.

TradeLink Capital first reported a position in BMY in Q2 2013 and held it in 4 quarters. The position peaked at $1.46M in Q2 2013. 2,214 funds tracked by Wall St. Rank hold BMY as of Q3 2020.

TradeLink Capital reported no remaining Bristol-Myers Squibb position as of Q3 2020 after selling out during the quarter.
TradeLink Capital sold 5,280 Bristol-Myers Squibb shares in Q3 2020, an estimated $310K.
TradeLink Capital first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 4 quarters.
TradeLink Capital's Bristol-Myers Squibb position peaked at $1.46M in Q2 2013.
2,214 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2020.

Based on TradeLink Capital's 13F filing for Q3 2020, filed 2 Nov 2020.